Correlation Between Mitake Information and Alar Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mitake Information and Alar Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mitake Information and Alar Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mitake Information and Alar Pharmaceuticals, you can compare the effects of market volatilities on Mitake Information and Alar Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mitake Information with a short position of Alar Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mitake Information and Alar Pharmaceuticals.
Diversification Opportunities for Mitake Information and Alar Pharmaceuticals
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Mitake and Alar is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Mitake Information and Alar Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alar Pharmaceuticals and Mitake Information is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mitake Information are associated (or correlated) with Alar Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alar Pharmaceuticals has no effect on the direction of Mitake Information i.e., Mitake Information and Alar Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mitake Information and Alar Pharmaceuticals
Assuming the 90 days trading horizon Mitake Information is expected to generate 0.31 times more return on investment than Alar Pharmaceuticals. However, Mitake Information is 3.21 times less risky than Alar Pharmaceuticals. It trades about 0.35 of its potential returns per unit of risk. Alar Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 6,500 in Mitake Information on September 12, 2024 and sell it today you would earn a total of 430.00 from holding Mitake Information or generate 6.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mitake Information vs. Alar Pharmaceuticals
Performance |
| Timeline |
| Mitake Information |
| Alar Pharmaceuticals |
Mitake Information and Alar Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mitake Information and Alar Pharmaceuticals
The main advantage of trading using opposite Mitake Information and Alar Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mitake Information position performs unexpectedly, Alar Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will offset losses from the drop in Alar Pharmaceuticals' long position.| Mitake Information vs. APEX International Financial | Mitake Information vs. K Way Information | Mitake Information vs. YuantaP shares Taiwan Electronics | Mitake Information vs. YuantaP shares Taiwan Top |
| Alar Pharmaceuticals vs. Syntek Semiconductor Co | Alar Pharmaceuticals vs. Sesoda Corp | Alar Pharmaceuticals vs. First Hotel Co | Alar Pharmaceuticals vs. Mospec Semiconductor Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |